Search

everythinglearnresearchcommunity

for

Search:↓

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Managing diabetes can lead to eating disorders, and eating disorders can make diabetes harder to control.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

Obesity can worsen wound healing by negatively affecting the function of stem cells in fat tissue.

Cobalt is important for health but too much or too little can cause health problems, and its environmental buildup is a concern.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Hydrogels combined with extracellular vesicles and 3D bioprinting improve wound healing.

PRP helps skin heal, possibly through special cells called telocytes.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

CBD may improve skin and hair health, but its effective use and safety need more research.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Placenta products might help with hair loss, but more research is needed.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

PRP shows promise but lacks consistent evidence and regulation.

Stem-cell therapy shows promise for skin conditions but needs more research.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The CuCS/Cur wound dressing helps regenerate nerves and heal deep skin burns by rebuilding hair follicles.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.